In this episode, we discuss America’s most complex systems—our healthcare and pharmaceutical industries. From rising costs and drug pricing to employee benefits and AI/biotech breakthroughs, we unpack the forces shaping the care we depend on.

We break down the root causes behind rising healthcare costs, how employers are grappling with rising insurance premiums, and discuss the role of HSAs and wellness incentives, and what this all means for employees.

We also take listeners through the drug development lifecycle, from R&D to market, and candidly discuss the lack of pricing transparency. And as the episode unfolds, we will explore how AI and robotics are driving innovation, and how they are poised to redefine modern medicine.

We dive into healthcare trends, reforms, affordability and the forces shaping healthcare. Ultimately, we ponder big questions: Can innovation and affordability truly coexist? and Is there a prescribed remedy for the broken healthcare system?

Whether you work in healthcare, HR, or simply care about your own wellbeing, Vital Signs keeps you informed of what’s ahead.

Lynn Gargano

Lynn Gargano

Editor of the Financial Executives Journal and a strategic advisor to The Financial Executives Networking Group (FENG), where she contributes to thought leadership, business strategy, and the continued expansion of the organization’s digital and content platforms.

Lynn is an accomplished, business-savvy, senior financial executive and thought leader with an entrepreneurial mindset, focused on driving value creation. She has a strong financial acumen and deep understanding of financial levers with extensive experience in Financial Services, Asset and Wealth Management subsectors. Lynn is a collaborative leader, who bridges finance and strategic growth, turning insight into a growth engine, that drives P&L performance, unlocks revenue opportunities, guides strategic decision-making, and cultivates strategic partnerships.

Her background includes Big 4 public accounting, shaping her perspective on financial reporting, planning, and finance transformation.

Andrew Silverman

Andrew Silverman

Lead Transactional & Tax Policy Strategist at Bloomberg Intelligence

Senior tax policy and transactional analyst at Bloomberg Intelligence, a platform within Bloomberg Professional Services on the Bloomberg Terminal.

I have a broad tax, policy and transactional focus. I write about international and US federal and state tax change, the OECD BEPS initiative, tax controversy, transfer pricing and tax issues related to M&A and capital markets. I also cover M&A, IPOs and other corporate transitions.

I appear on Bloomberg Radio and TV to discuss tax issues, corporate actions and policy prognostication.

Dr. Shealynn Buck

Dr. Shealynn Buck

Dr. Buck is Lockton People Solutions’ Chief Medical Officer and clinical leader of Lockton’s Advanced Medical Advisory Practice. Dr. Buck brings together the collective intelligence of Lockton’s healthcare experts, serves as a strategic consultant to U.S. employer on complex healthcare issues, and specializes in clinical data intelligence to help employers make the best decisions for their people and plan. She is the co-chair of Lockton’s Clinical Advisory Practice, an interdisciplinary thought leadership team composed of population health, pharmacy, and medical consulting leaders. Dr. Buck has also served as the clinical leader of Lockton’s Coronavirus Advisory Practice during COVID, and the practice leader of Lockton Dunning Precision Health Practice.
Prior to joining Lockton, Dr. Buck served as a medical director and vice president of health integration at Marsh & McLennan Agency, executive medical director of DeKalb Medical Center in Atlanta tasked with oversight of healthcare worker occupational health & safety and employer-directed services, Sr. Medical Laboratory Director of Quintiles Laboratories North America, which involved drug development consulting to the biopharmaceutical industry, and Assistant Medical Director at American Red Cross Biomedical Services.

Ted Pizzo

Ted Pizzo

Ted Pizzo is a Managing Executive with Lockton. Lockton provides several thousand clients around the world with risk management, insurance, talent solutions and employee benefits consulting services. Lockton is the world’s largest privately owned, independent insurance broker with 125+ offices on six continents..

Ted is also the President of the National Executive Advisory Group, which he founded in 2004. The National Executive Advisory Group (NEAG) includes thousands of executives, professionals and community leaders who help each other grow their respective businesses, offer support with referrals, collaborate on philanthropic endeavors and assist those between jobs land in the right place.

Matt Henriksson

Matt Henriksson

Matt Henriksson, CFA, is the Senior Medical Technology Analyst at Bloomberg Intelligence, covering 22 companies across the cardiology, orthopedic, diabetes, and robotic markets. He is also co-host of the Vanguards of Health Care series. Prior to joining Bloomberg he was an equity analyst at Citi Research, covering small and mid-cap orthopedic companies. Matt started his career at Advanced Portfolio Management before moving to equity research at BMO Capital Markets. He holds an MBA degree from Fordham University and a bachelor’s degree from Franklin & Marshall College, majoring in economics.

Leave a Reply

Your email address will not be published.